Select Medical Holdings

Select Medical Holdings Corp. engages in the provision of medical rehabilitation services. It operates through the following segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation and Concentra. The Critical Illness Recovery Hospital segment serves patients with debilitating injuries and rehabilitation needs that cannot be adequately cared in a medically intensive environment, such as a skilled nursing facility. The Rehabilitation Hospital segment provides physical medicine, as well as rehabilitation programs and services, which serve to optimize patient health, function, and quality of life. The Outpatient Rehabilitation segment provides physical, occupational, and speech rehabilitation services through its clinics. The Concentra segment operates through its medical centers and contract services provided at employer worksites and Department of Veterans Affairs community-based outpatient clinics, which deliver occupational medicine, physical therapy, veteran’s healthcare, and consumer health services. The company was founded by Robert A. Ortenzio and Rocco A. Ortenzio in 1996 and is headquartered in Mechanicsburg, PA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Select Medical Holdings reports strong Q4 results and growth outlook

Select Medical Holdings demonstrated financial strength and growth potential in Q4 2022 across its divisions.
While challenges like labor market uncertainty persist, opportunities for revenue growth and strategic expansion are evident.
The company's focus on cost management and operational efficiency bodes well for future performance and stakeholder engagement.

Select Medical Holdings posts strong Q1 results, eyes growth

Select Medical Holdings (SEM) reported robust Q1 2023 results, showcasing growth across all divisions and a positive outlook for the year ahead.
The company's focus on cost management, strategic investments, and operational efficiency positions it well for continued success and market expansion.
While facing challenges such as revenue fluctuations and rising interest expenses, Select Medical Holdings remains proactive in addressing operational and financial hurdles.
Opportunities for growth through market expansion, technology utilization, and strategic initiatives underscore a promising trajectory for the company.

Select Medical Holdings reports strong Q2 performance and growth outlook

Select Medical Holdings (SEM) demonstrated robust financial performance in Q2 2023, driven by revenue growth and improved EBITDA across divisions.
The company's strategic refinancing and positive industry recognition position SEM well for future growth and operational excellence.
While facing challenges in maintaining exceptional growth rates, SEM has opportunities to capitalize on its strengths and market positioning for sustained success.

Select Medical Holdings (SEM) reports strong Q3 performance and expansion plans

Select Medical Holdings (SEM) demonstrated robust financial growth in Q3 2023, driven by improvements in various divisions.
The company's focus on expansion through new hospital openings and partnerships presents promising opportunities for future growth.
Overall, Select Medical Holdings (SEM) is well-positioned for continued success and value creation for its shareholders.

Select Medical Holdings reports strong Q4 results and growth opportunities

SEM's strong performance in Q4 2023 and strategic initiatives position the company for growth and value creation.
While facing challenges such as projected start-up losses and increased interest expenses, SEM is actively pursuing opportunities for financial optimization.
The company's focus on separating Concentra, expanding partnerships, and managing capital allocation underscores its commitment to enhancing shareholder value.
Investors should monitor SEM's progress in executing its 2024 outlook and addressing financial challenges to assess future performance.

Select Medical Holdings posts robust Q1 results and outlines growth plans

Select Medical Holdings (SEM) reported strong financial and operational performance in Q1 2024, driven by revenue growth, margin expansion, and strategic initiatives.
While facing challenges in working capital management and capital allocation decisions, SEM's focus on efficiency and growth presents opportunities for value creation and market expansion.
Investors should monitor SEM's progress in executing its growth plans, managing debt levels, and capitalizing on opportunities in the healthcare services sector.

Select Medical Holdings reports solid Q2 performance and expansion plans

Select Medical Holdings delivered a strong Q2 performance with revenue and EBITDA growth across key divisions.
The company's focus on expansion, quality healthcare services, and shareholder returns positions it well for future growth.
While facing challenges like earnings per share decline and regulatory changes, Select Medical has opportunities for market expansion and service enhancement.
Investors should monitor Concentra's performance details and the company's strategic execution in new hospital developments.

Select Medical Holdings reports strong Q3 performance and expansion plans

Select Medical Holdings delivered a robust performance in Q3, with strong revenue and EBITDA growth across all divisions.
The company's expansion plans and strategic projects indicate a focus on long-term growth and market presence.
While facing challenges in managing expansion and financing, Select Medical has opportunities to capitalize on sector growth and operational improvements.
Investors can be optimistic about Select Medical's financial health, demonstrated by the declared cash dividend and positive performance indicators.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Select Medical Holdings Corp. engages in the provision of medical rehabilitation services. It operates through the following business segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation and Concentra. The Critical Illness Recovery Hospital segment serves patients with debilitating injuries and rehabilitation needs that cannot be adequately cared for in a medically intensive environment, such as a skilled nursing facility. The Rehabilitation Hospital segment provides physical medicine, as well as rehabilitation programs and services, which serve to optimize patient health, function, and quality of life. The Outpatient Rehabilitation segment offers physical, occupational, and speech rehabilitation services through its clinics. The Concentra segment operates through its medical centers and contract services provided at employer worksites and Department of Veterans Affairs community-based outpatient clinics, which deliver occupational medicine, physical therapy, veteran’s healthcare, and consumer health services. The company was founded by Robert A. Ortenzio and Rocco A. Ortenzio in 1996 and is headquartered in Mechanicsburg, PA.

Cars.com

Innoviva

Everything is expensive these days including stocks. Amid a raging bull market, it is tough to find affordable stocks to buy.

The 3 Most Undervalued Under-$50 Stocks to Buy in July 2024

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Here's Why Select Medical (SEM) is a Strong Value Stock

MECHANICSBURG, Pa. , June 28, 2024 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE: SEM), will release the financial results for its second quarter ended June 30, 2024 on Thursday, August 1, 2024 after the market closes.

Select Medical Holdings Corporation to Announce Second Quarter 2024 Results on Thursday, August 1, 2024

Why Select Medical (SEM) is a Top Momentum Stock for the Long-Term

MECHANICSBURG, Pa. , June 26, 2024 /PRNewswire/ -- Select Medical Holdings Corporation ("Select") (NYSE: SEM) and Concentra Group Holdings Parent, Inc. ("Concentra"), today announced that Concentra Escrow Issuer Corporation ("Issuer"), a wholly-owned subsidiary of Concentra Health Services, Inc. ("CHSI"), has priced its offering of $650 million aggregate principal amount of 6.875% senior notes due 2032.

Select Medical Holdings Corporation and Concentra Group Holdings Parent, Inc. Announce Pricing of Offering of $650 Million of 6.875% Senior Notes due 2032 by Concentra Escrow Issuer Corporation

MECHANICSBURG, Pa. , June 25, 2024 /PRNewswire/ -- Select Medical Holdings Corporation ("Select") (NYSE: SEM) and Concentra Group Holdings Parent, Inc. ("Concentra") today announced that Concentra Escrow Issuer Corporation ("Issuer"), a wholly-owned subsidiary of Concentra Health Services, Inc. ("CHSI"), commenced an offering of $750 million in aggregate principal amount of senior notes due 2032.

Select Medical Holdings Corporation and Concentra Group Holdings Parent, Inc. Announce Commencement of Offering of $750 Million of Senior Notes by Concentra Escrow Issuer Corporation

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Why Select Medical (SEM) is a Top Value Stock for the Long-Term

Select Medical (SEM) will continue to gain from rising admissions within the Critical Illness Recovery Hospital and Rehabilitation Hospital segments.

Select Medical (SEM) Rises 42.4% YTD: More Growth Ahead?

Select Medical (SEM) revises its adjusted EBITDA guidance upward between $845 million and $885 million for 2024, the mid-point is higher than $807.4 million in 2023.

Select Medical's (SEM) Shares Up 12.9% Since Q1 Earnings Beat

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Is Select Medical (SEM) a Great Value Stock Right Now?

Select Medical Holdings Corporation (NYSE:SEM ) Q1 2024 Earnings Conference Call May 3, 2024 9:00 AM ET Company Participants Robert Ortenzio - Chief Executive Chairman and Co-Founder Martin Jackson - Senior EVP, Strategic Finance & Operations Conference Call Participants Justin Bowers - Deutsche Bank Ben Hendrix - RBC Capital Markets A.J. Rice - UBS Bill Sutherland - The Benchmark Company Operator Good morning and thank you for joining us today for Select Medical Holdings Corporation's Earnings Conference Call to discuss the First Quarter 2024 Results and the company's Business Outlook.

Select Medical Holdings Corporation (SEM) Q1 2024 Earnings Call Transcript

MECHANICSBURG, Pa. , May 2, 2024 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE: SEM) today announced results for its first quarter ended March 31, 2024, and the declaration of a cash dividend.

Select Medical Holdings Corporation Announces Results For Its First Quarter Ended March 31, 2024 and Cash Dividend

MECHANICSBURG, Pa. , April 5, 2024 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE: SEM), will release the financial results for its first quarter ended March 31, 2024 on Thursday, May 2, 2024 after the market closes.

Select Medical Holdings Corporation to Announce First Quarter 2024 Results on Thursday, May 2, 2024

Select Medical (SEM) inks a joint venture agreement with UF Health Jacksonville to open a 48-bed inpatient rehabilitation hospital in Florida.

Select Medical (SEM) Expands in Florida With UF Health JV

Broadcom

Delta Air Lines

Match Group

Micron Technology

Netflix

Pfizer

There are some stocks to make friends envious for March this year. These companies have impressive growth prospects and strong fundamentals that position them for potential outperformance.

7 Stocks That Will Make Your Friends Green with Envy

The move from Select Medical's (SEM) Concentra highlights the recovery in the U.S. IPO market, especially for healthcare companies.

Select Medical's (SEM) Concentra Submits Confidential IPO Filing

ADDISON, Texas , March 18, 2024 /PRNewswire/ -- Concentra Group Holdings Parent, Inc. ("Concentra") today announced that it has confidentially submitted a draft registration statement on Form S-1 with the U.S. Securities and Exchange Commission (the "SEC") relating to the proposed initial public offering of its common stock. The number of shares to be offered and the price range for the proposed offering have not yet been determined.

Concentra Announces Confidential Submission of Draft Registration Statement Related to Proposed Public Offering

Select Medical operates specialty hospitals and outpatient rehabilitation clinics, providing care for patients with complex medical conditions.

Select Medical: Solid Growth Prospects And A Compelling Valuation

MECHANICSBURG, Pa., Feb. 27, 2024 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE: SEM)  announced today that it has received a favorable private letter ruling from the Internal Revenue Service (the "IRS") with respect to the tax-free status of its previously announced plan to pursue a separation of its wholly-owned occupational health services business, Concentra Group Holdings Parent, LLC ("Concentra" and such business, the "Concentra business").

Select Medical Holdings Corporation Receives Favorable IRS Private Letter Ruling on Tax-Free Nature of Its Previously Announced Potential Separation of Concentra

Select Medical Holdings Corporation (SEM) Q4 2023 Earnings Call Transcript

Select Medical's (SEM) Q4 results reflect strong segmental contribution, aided by higher patient days and visits. Management expects 2024 adjusted EBITDA to be $830-$880 million, up from the 2023 reported figure of $807.4 million.

Select Medical (SEM) Q4 Earnings Beat on Patient Admissions

Select Medical (SEM) came out with quarterly earnings of $0.36 per share, beating the Zacks Consensus Estimate of $0.31 per share. This compares to earnings of $0.22 per share a year ago.

Select Medical (SEM) Tops Q4 Earnings and Revenue Estimates

MECHANICSBURG, Pa. , Feb. 22, 2024 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE: SEM) today announced results for its fourth quarter and year ended December 31, 2023 and the declaration of a cash dividend.

Select Medical Holdings Corporation Announces Results For Its Fourth Quarter and Year Ended December 31, 2023 and Cash Dividend

Select Medical's (SEM) fourth-quarter results are likely to reflect growing visits in Outpatient Rehabilitation and Concentra.

Can Low Occupancy Rate Affect Select Medical (SEM) Q4 Earnings?

Select Medical (SEM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

News for Select Medical Holdings Stock (SEM)